EMN for Traceability in Laboratory Medicine

Laboratory testing is at the heart of modern health care: an estimated 70% of medical decisions depend on in vitro diagnostics (IVDs). Benefits for patients, healthcare providers and the IVD industry are improved when robust and metrologically traceable IVDs are used to provide accurate test results irrespective of the laboratory, the IVD provider, or the instrumentation used for testing.

Metrological traceability of IVDs enhances validity of diagnosis, supports further treatment, and lowers the financial burden on healthcare systems by avoiding nonessential testing. Traceability is also an important aspect of regulatory schemes: IVD manufacturers need to comply with legal requirements for traceability to gain and maintain market access.

These requirements are defined in the regulation on in vitro diagnostic medical devices EU 2017/746 (IVDR) and include metrological traceability of calibrator and control material values along with testing of highrisk IVDs by EU reference laboratories. The European network on Traceability in Laboratory Medicine (TraceLabMed) was established to build a coordinated metrologybased quality infrastructure in an area that affects almost every European citizen.

For download: Overview of EMN TraceLabMed (PDF)

EMN Chair

Vincent Delatour, LNE, France

TLM News

See all EURAMET news
EMPIR project enables biotechnology guidance to be included in new standards
New standards will improve nucleic acid and cell counting measurements to support advances in biotechnology
A new standard to help with the fight against blindness
Glaucoma is the leading cause of blindness, and now an EMPIR project has provided metrological validation for instruments that detect the main risk fa...
Laboratory Medicine Network candidates elected for next term
TraceLabMed members vote in a new chair & vice-chair, and re-elect network secretary for another term